Trinity Biotech PLC
NASDAQ:TRIB
Trinity Biotech PLC
Additional Paid In Capital
Trinity Biotech PLC
Additional Paid In Capital Peer Comparison
Competitive Additional Paid In Capital Analysis
Latest Figures & CAGR of Competitors
Company | Additional Paid In Capital | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Trinity Biotech PLC
NASDAQ:TRIB
|
Additional Paid In Capital
$49.9m
|
CAGR 3-Years
46%
|
CAGR 5-Years
25%
|
CAGR 10-Years
18%
|
|
Medtronic PLC
NYSE:MDT
|
Additional Paid In Capital
$23.1B
|
CAGR 3-Years
-4%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
|
STERIS plc
NYSE:STE
|
Additional Paid In Capital
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Trinity Biotech PLC's Additional Paid In Capital?
Additional Paid In Capital
49.9m
USD
Based on the financial report for Mar 31, 2024, Trinity Biotech PLC's Additional Paid In Capital amounts to 49.9m USD.
What is Trinity Biotech PLC's Additional Paid In Capital growth rate?
Additional Paid In Capital CAGR 10Y
18%
Over the last year, the Additional Paid In Capital growth was 7%. The average annual Additional Paid In Capital growth rates for Trinity Biotech PLC have been 46% over the past three years , 25% over the past five years , and 18% over the past ten years .